by Seth J. Rotz, Nathan Luebbering, Bradley P

Slides:

Advertisements

Similar presentations

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Advertisements

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

Dasatinib suppresses in vitro natural killer cell cytotoxicity

BK Viremia Precedes Hemorrhagic Cystitis in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Benjamin L. Laskin, Michelle Denburg,

Next-generation leukemia immunotherapy

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations by Mark J. Levis, Alexander E.

Nonmyeloablative conditioning for relapsed follicular lymphoma

Mutagenic potential of temozolomide in bone marrow cells in vivo

Biology of Blood and Marrow Transplantation

Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation Javier.

Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children by Ayami Yoshimi, Charlotte.

Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute.

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

by Ineke J. M. ten Berge, and René A. W. van Lier

Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal,

Anergy: the CLL cell limbo

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

Activity of eltrombopag in severe aplastic anemia

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD by Nelli Bejanyan, Claudio G. Brunstein,

Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant–Associated Thrombotic Microangiopathy Sonata Jodele, Russel.

Early Soluble ST2 Elevation Predicts Future Left Ventricular Systolic Dysfunction after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Thomas D.

Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Abigail Pate, Mikako Warren,

Pulmonary Hypertension after Hematopoietic Stem Cell Transplantation

Pauline A. Daniels, DO, Stella M

A Single Ultra High Dose of Vitamin D is Safe and Feasible in Early Peri-Transplant Period to Prevent Vitamin D Deficiency in Pediatric HSCT Recipients

Gregory Wallace, Sonata Jodele, Jonathan Howell, Kasiani C

Seth Joshua Rotz, Nathan Luebbering, Bradley P. Dixon, Christopher E

Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study Parinda.

Increased Vitamin D Binding Protein Levels Are Associated with Improved Overall Survival Following Bone Marrow Transplant in Children Nathan Luebbering,

Endothelial Injury, Neutrophil Extracellular Traps, and Complement Activation in Thrombotic Microangiopathy and GVHD Nicholas J. Gloude, Sonata Jodele,

by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A

Biology of Blood and Marrow Transplantation

Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing Benjamin.

by Kaiwen Chen, Matthew P. Cheng, Sarah P

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant.

Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT Javier El-Bietar, MD, Mikako Warren, MD, Christopher.

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Volume 2(Supplement 1):1-3

Sonata Jodele, Kejian Zhang, Christopher E. Dandoy, Kasiani C

Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease by Margaret T. Lee, Meyer Kattan,

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma by Tineke Casneuf, Xu Steven.

Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.

Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans by Anne Jan van der Meer, Anna Kroeze,

by Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F

Translational efficiency of ATM, MRN complex, and RIF1.

Volume 2(Supplement 1):46-49

by Michael R. DeBaun, and Ellen Wright Clayton

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods by Mikhail Roshal, Juan A. Flores-Montero,

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

Bridge to transplant following Bv+Bs regimen.

Treatment versus Transplant for Challenging Hematologic Disorders

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation Nikhil Dole, Nathan Luebbering, Nicholas.

Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues? Seth Joshua Rotz, MD, Thomas D. Ryan,

CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking by Juliet N. Barker, Jane Kempenich, Joanne.

Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis by Juliet N. Barker, Kirsten Boughan, Parastoo.

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor.

Resistance mechanism for ibrutinib in marginal zone lymphoma

Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation– Associated Thrombotic Microangiopathy Sonata Jodele, Tsuyoshi Fukuda,

by Catherine Lai, Vishal Ranpura, Colin Wu, Matthew J. Olnes, Ankur R

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Volume 2(Supplement 1):4-7

Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory- Confirmed Bloodstream Infections after Stem Cell Transplantation Christopher.

Presentation transcript:

In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy by Seth J. Rotz, Nathan Luebbering, Bradley P. Dixon, Eleni Gavriilaki, Robert A. Brodsky, Christopher E. Dandoy, Sonata Jodele, and Stella M. Davies BloodAdv Volume 1(20):1632-1634 September 12, 2017 © 2017 by The American Society of Hematology

WST-1 viability assay on PIGA-mutant TF-1 cells. WST-1 viability assay on PIGA-mutant TF-1 cells. Percentage of nonviable cells (circles), with median (wide horizontal line) and interquartile range (narrow horizontal line). LPS, lipopolysaccharide. Seth J. Rotz et al. Blood Adv 2017;1:1632-1634 © 2017 by The American Society of Hematology